Work

Recombinant von Willebrand Factor (vonicog alfa) reduces platelet inhibition caused by antiplatelet drugs and has potential as an acute haemostatic agent

Year: 2026

Type: article

Abstract: Not available.

Source: Haematologica

DOI: 10.3324/haematol.2025.289179

Authors: Michael J.R. Desborough, Joanne L. Mitchell, Polly Whitworth, Ashifa Al Juwaiser, Tanya Sage, Neline Kriek, Gemma Little, Sakthivel Vaiyapuri, Jonathan M. Gibbins, Alexander P. Bye

Institutions: NHS Blood and Transplant, University of Oxford, Oxford University Hospitals NHS Trust, University of Birmingham, John Radcliffe Hospital, University of Reading

Language: English

Topic: Platelet Disorders and Treatments

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

Estimated APC paid: $2,157

Funders: British Heart Foundation, Rosetrees Trust, National Institutes of Health

Award: Understanding differences in platelet function and regulation in health and cardiometabolic disease: towards personalised and more effective anti-platelet treatment (renewal)

OpenAlex ID: W7125394248

FWCI:

Cites:

Cited by:

Related to: